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Abstract
Natural killer (NK) cells provide important host defense against herpesvirus infections and influence subsequent T cell 
control of replication and maintenance of latency. NK cells exhibit phases of expansion, contraction and memory formation 
in response to the natural mouse pathogen murine cytomegalovirus (MCMV). Innate and adaptive immune responses are 
tightly regulated in mammals to avoid excess tissue damage while preventing acute and chronic viral disease and assuring 
resistance to reinfection. Caspase (CASP)8 is an autoactivating aspartate-specific cysteine protease that initiates extrinsic 
apoptosis and prevents receptor interacting protein (RIP) kinase (RIPK)1–RIPK3-driven necroptosis. CASP8 also promotes 
death-independent signal transduction. All of these activities make contributions to inflammation. Here, we demonstrate 
that CASP8 restricts NK cell expansion during MCMV infection but does not influence NK memory. Casp8−/−Ripk3−/− 
mice mount higher NK response levels than Casp8+/−Ripk3−/− littermate controls or WT C57BL/6 J mice, indicating that 
RIPK3 deficiency alone does not contribute to NK response patterns. MCMV m157-responsive  Ly49H+ NK cells support 
increased expansion of both  Ly49H− NK cells and CD8 T cells in Casp8−/−Ripk3−/− mice. Surprisingly, hyperaccumulation 
of NK cells depends on the pronecrotic kinase RIPK1. Ripk1−/−Casp8−/−Ripk3−/− mice fail to show the enhanced expansion 
of lymphocytes observed in Casp8−/−Ripk3−/− mice even though development and homeostasis are preserved in uninfected 
Ripk1−/−Casp8−/−Ripk3−/− mice. Thus, CASP8 naturally regulates the magnitude of NK cell responses in response to infec-
tion where strong activation signals depend on another key regulator of death signaling, RIPK1. In addition, the strong NK 
cell response promotes survival of effector CD8 T cells during their expansion. Thus, hyperaccumulation of NK cells and 
crosstalk with T cells becomes amplified in the absence of extrinsic cell death machinery.
Keywords Apoptosis · Necroptosis · Cell death · Proliferation · Herpesvirus · Ripoptosome
Introduction
NK cells are innate lymphocytes that contribute to early con-
trol of virus infections. NK-dependent antiviral responses 
develop rapidly and exhibit robust cytotoxicity [1]. Activa-
tion depends on receptors that override inhibitory signals 
and trigger NK cell expansion, contraction, memory for-
mation [2]. Murine cytomegalovirus (MCMV) has yielded 
invaluable insights into antiviral NK cell function due to 
the ability of virus-encoded MHC class I-like glycopro-
tein m157 to specifically engage host Ly49H, an activating 
receptor mediating robust proliferation and strong cytotoxic 
effector responses [3] that dictate early control over MCMV 
[4, 5]. Following peak expansion, most  Ly49H+ NK cells 
contract to leave a memory-like population that persists [6] 
in a manner reminiscent of the adaptive T cell response. 
Human (H)CMV-infected individuals have higher persistent 
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levels of  CD94+NKG2C+ NK cells compared to seronega-
tive individuals [7, 8], suggesting that NK cell memory also 
follows HCMV infection. Given that comparable patterns 
of memory have been observed in humans [9] and mice [6], 
MCMV-infected mice help to provide mechanistic insights 
into memory NK cell generation.
In addition to the Ly49H receptor, NK cell expansion 
depends on proinflammatory cytokines and costimulatory 
receptors. IL-12, IL-18, IL-33 and type I IFNs regulate NK 
cell proliferation, cytotoxic function and memory formation 
[10]. IL-12-triggered, STAT4-dependent signal transduc-
tion upregulates MyD88 and consequent expression of the 
IL-18 receptor to promote NK cell proliferation [11]. Type 
I IFN-induced transcription factors STAT1, STAT2, IRF8 
and IRF9 all contribute to NK cell survival during expansion 
[12–14]. In addition, both IL-12 and type I IFN promote NK 
cell cytotoxic function and IFNγ production [15, 16]. Sign-
aling through NKG2D augments m157-dependent  Ly49H+ 
NK proliferation, although stimulation via NKG2D alone is 
not sufficient to trigger NK cell expansion [17]. All of these 
factors contribute to the levels, differentiation programs and 
longevity of NK cells, which is mediated by the balance of 
proliferation and death.
Lymphocyte turnover and cell death occur primarily via 
cell-intrinsic apoptosis, mediated by Bcl2 family member 
Bim acting upstream of Bax- and Bak-dependent mitochon-
drial outer membrane permealization (MOMP) and release 
of cytochrome c [18, 19]. Similar to its role in antiviral T cell 
contraction, Bim functions during  Ly49H+ NK cell contrac-
tion and formation of a memory pool [20, 21]. Extrinsic cell 
death is activated by cell-surface TNF receptor superfam-
ily death receptors (DRs, including Fas, as well as TNFR1 
and TRAIL) that drive cytosolic events resulting in death-
dependent (apoptotic, necroptotic) and death-independent 
signaling outcomes [22–25]. Fas death receptor-mediated 
signaling and Bid amplification of signals [19] contribute 
to T cell homeostatic turnover [25]. Fas also contributes to 
contraction following herpesvirus infection [26]. We have 
recently shown that CASP8-dependent extrinsic apop-
tosis is dispensable for NK or T cell contraction during 
MCMV or HSV1 infection of viable and immunocompe-
tent Casp8−/−Ripk3−/− mice [27, 28], a topic that is elabo-
rated in the accompanying review. Our data are consistent 
with the predominant role of the intrinsic pathway in the 
shutdown of acute NK cell responses following clearance 
of viral antigens.
CASP8 was initially believed to support lymphocyte 
activation due to defective NF-κB signaling via CD244 (or 
2B4) and CD16 in mice with T cell-specific deficiency [29, 
30], events likely to result from the vital role that CASP8 
plays in suppressing RIPK3-mediated necroptosis [31]. 
Our recent study of Casp8−/−Ripk3−/− mice reveals that 
the  Ly49H+ NK cell expansion peaks higher compared 
to either Casp8+/−Ripk3−/− or WT C57BL/6  J controls 
during the acute phase of MCMV infection [27], indicat-
ing that CASP8 restricts  Ly49H+ NK cell expansion in a 
necroptosis-deficient background. However, the interpreta-
tion of these results is complicated by other environmental 
considerations, including viral antigen load as well as the 
abnormal  B220+CD3+ T cell accumulation [27, 31] and 
enhanced DCs numbers that accompany MCMV infection 
in Casp8−/−Ripk3−/− mice [27].
In this study, we show that CASP8 restricts  Ly49H+ NK 
cell accumulation as well as effector differentiation but is 
dispensable for memory NK cell development. While our 
previous study has shown that  Ly49H+ NK cell hyperaccu-
mulation in Casp8−/−Ripk3−/− mice requires m157 MCMV 
antigen, data from the current work show that enhancement 
requires active virus replication. Further, using a co-transfer 
system, it appears that CASP8 makes a cell-autonomous con-
tribution to restricting NK cell expansion. Strikingly, RIPK1 
elimination in Casp8−/−Ripk3−/− mice completely ablates 
NK cell responses, although Ripk1−/−Casp8−/−Ripk3−/− mice 
exhibit normal homeostatic NK cell development [32]. 
Finally, Casp8−/−Ripk3−/− NK cells support robust memory 
development that results in normal levels of  CD11bloCD27+ 
and higher percentages of  Ly6C+ and  KLRG1hi subsets 
when compared with WT mice.
Materials and methods
Mice, viruses and experimental infection
C a s p 8 − / − R i p k 3 − / −  [ 3 1 ]  a n d  C a s p 8 − / − 
Ripk3K51A/K51A [33] mice were > 97% C57BL/6  J. 
Casp8−/−Ripk3−/− and Casp8+/−Ripk3−/− littermates 
were generated by mating Casp8−/−Ripk3−/− and 
Casp8+/−Ripk3−/− mice. Ripk1−/−Casp8−/−Ripk3−/− mice 
were generated as described previously [32]. C57BL/6 J 
mice were obtained from The Jackson Laboratory, used 
for backcrossing and bred at Emory University Division of 
Animal Resources. K181-BAC-derived WT virus and K181-
BAC-derived ∆m157, kindly provided by Wolfram Brune 
(Heinrich Pette Institute), were propagated in NIH3T3 fibro-
blasts. Mice were inoculated intraperitoneally with 1 × 106 
PFU virus per mouse. The cell culture medium was purified 
and concentrated for virus stock preparation, which were 
stored in single-use aliquots at − 80 °C until use.
Plaque assay
Homogenized tissue in DMEM medium was overlaid on 
NIH3T3 cells plated in 6-well plates. On day 4 post infec-
tion, cells were fixed with methanol and stained with Giemsa 
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for visualizing plaques that were counted with the aid of a 
dissecting microscope.
Antibodies
For flow cytometry, antibodies to CD16/CD32 (FcγRII/III; 
Clone 2.4G2), CD45 (Clone 30-F11), CD45.1 (Clone A20), 
CD45.2 (Clone 104), CD11b (Clone M1/70), NK1.1 (Clone 
PK136), B220 (Clone RA3-6B2), CD3ε (Clone 17A2), 
CD3ε (Clone 145-2C11), CD8 (Clone 53–6.7), KLRG1 
(Clone 2F1), Ki67 (Clone SolA15) were from BD PharMin-
gen; and CD3ε (Clone 17A2) were from BioLegend; and 
Ly49H (Clone 3D10) was from eBioscience. For Annexin 
V analysis, splenocytes harvested from mice were stained 
with Annexin V (BD Bioscience).
Flow cytometry
Spleens were harvested from euthanized mice, and were 
pressed through metal sieves for organ disruption. Cells 
were then incubated with red blood cell lysis buffer and 
then passed through a 100-mm strainer. In all experiments, 
2 × 106 viable cells, as determined by trypan blue exclusion, 
were stained with antibodies specific for surface and intra-
cellular proteins and were prepared for detection by flow 
cytometry (BD LSRII cytometer and FACSDiva Software; 
BD Biosciences). Data were analyzed with FlowJo (TreeS-
tar), and graphed with Prism 7 (GraphPad).
Results
MCMV-infected mice deficient in CASP8 and RIPK3 show 
enhanced  Ly49H+ NK cell accumulation compared to con-
trols [27]. Thus, similar to the cell-autonomous impact on 
CD8 T cells [27, 28], CASP8 naturally restricts  Ly49H+ NK 
cell expansion, once unleashed necroptosis has been elimi-
nated from the host. To determine whether enhancement was 
 Ly49H+ NK cell specific, the time course of  Ly49H+ and 
 Ly49H− NK cell expansion was determined. Splenocytes 
from Casp8−/−Ripk3−/−, Casp8+/−Ripk3−/− and WT mice 
were collected at various times following MCMV infection, 
and NK cell number and phenotype were assessed. Total NK 
cell numbers were comparable in all groups on days 1.5, 
3 and 5 post MCMV infection (Fig.  1a), but expanded 
to peak levels at 7 dpi that were dramatically higher in 
Casp8−/−Ripk3−/− mice relative to controls. A similar pat-
tern of contraction occurred in all mice from 9 to 14 dpi. The 
data suggest that CASP8 restricts NK cell numbers during 
the expansion phase but is dispensable for cell contraction, a 
pattern that has been observed with antiviral CD8 T cells in 
these mice [28]. Numbers of MCMV m157-driven  Ly49H+ 
NK cells [3] increased to significantly higher levels by 
7 dpi in Casp8−/−Ripk3−/− mice, as expected [27] (Fig. 1b); 
whereas, the numbers of  Ly49H− NK cells remained gener-
ally comparable independent of genotype over the two-week 
observation period (Fig. 1c). Consistent with the cell count 
analysis, percentages of  Ly49H+ NK cells were significantly 
higher in Casp8−/−Ripk3−/− mice at 7 dpi compared to WT 
and Casp8+/−Ripk3−/− controls, while levels were compara-
ble at 1.5 dpi independent of genotype (Fig. 1d). To further 
investigate whether Casp8 regulates cells through a cell-
autonomous or cell-extrinsic mechanism, equal numbers of 
CD45.1+ WT and CD45.2+ DKO NK cells were cotrans-
ferred into Ly49H-deficient mice. Expansion and contrac-
tion of  Ly49H+ NK cells were measured in peripheral blood 
following MCMV infection. DKO cells exhibited increased 
expansion with a peak that was higher than WT controls 
(Fig. 2a). Following the peak NK cell response,  Ly49H+ NK 
cells from both genotypes contracted between days 14 and 
28 post infection. Consistent with the enhanced accumula-
tion, DKO cells made up the majority of the total  Ly49H+ 
population throughout the infection (Fig. 2b). These data 
show that Casp8 mediates an NK cell-autonomous restric-
tion of expansion but is dispensable for contraction.
Upon infection, all three genotypes upregulated KLRG1 
on  Ly49H+ NK cells, suggesting that maturation occurs 
independently of CASP8 or RIPK3 (Fig. 1e). However, a 
higher proportion of Casp8−/−Ripk3−/−  Ly49H+ NK cells 
upregulated KLRG1 at 7 dpi, again reminiscent of respond-
ing CD8 T cells in these mice [28]. Taken together, CASP8 
appears to restrict m157-specific  Ly49H+ NK cell accumu-
lation following MCMV infection without playing a role in 
contraction.
Expansion of NK cells during antiviral prophylaxis
Next, we sought to investigate whether the NK cell response 
pattern depended on MCMV antigen levels. Differences 
between Casp8-deficient mice and controls do not result 
from differential viral replication levels or clearance [27, 
28]. Infected mice were treated with cidofovir (CDV) to 
inhibit virus replication, conditions where T cell expan-
sion patterns were preserved [28]. NK cell responses were 
investigated at 7 dpi where CDV effectively suppressed 
viral load to undetectable levels in these mice [28]. Com-
promised replication, which would be expected to reduce 
m157 levels markedly, did not impact total or  Ly49H+ NK 
cell responses, but reversed the heightened numbers in 
Casp8−/−Ripk3−/− mice (Fig. 3a). Interestingly, numbers 
of  Ly49H+ cells in CDV-treated Casp8−/−Ripk3−/− mice 
actually trended lower than in controls (Fig. 3b) which was 
reflected in reduced percentages as well (Fig. 3c). CDV-
compromised virus levels reduced the levels of NK cell dif-
ferentiation and percentages of  KLRG1hi  Ly49H+ NK cells, 
regardless of genotype (Fig. 3d). Nevertheless, independent 
 Medical Microbiology and Immunology
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Fig. 1  NK cell expansion, contraction, and differentiation dur-
ing the acute phase of MCMV infection. 6–8-week-old C57BL/6 
(WT), Casp8+/−Ripk3−/− (HET) and Casp8−/−Ripk3−/− (DKO) 
mice [31] were inoculated intraperitoneally (i.p.) with 1 × 106 PFU 
MCMV K181-BAC per mouse. Spleens were processed at 1.5, 
3, 5, 7, 9 and 14  days post infection (dpi) and stained with anti-
bodies specific for the indicated cell-surface markers. Splenic 
 CD45+B220−CD3−NK1.1+ NK cells were gated to identify  Ly49H+ 
and  Ly49H− NK cells. Graphs comparing numbers of total (a), 
 Ly49H+ (b), and  Ly49H− (c) NK cells. Data are presented as mean 
numbers ± S.E.M. Representative flow plots comparing the frequen-
cies of  Ly49H+ subset out of total NK cells (d). Representative his-
tograms showing the frequencies of  Ly49H+ NK cells expressing 
KLRG1 (e). C57BL/6 mice were from The Jackson Laboratory and 
maintained at Emory University Division of Animal Resources, and 
experimental procedures were conducted in accordance with the 
National Institutes of Health and Emory University Institutional Ani-
mal Care and Use Committee guidelines; K181-BAC virus strain was 
propagated in NIH3T3 cells, purified and concentrated from clari-
fied cell culture medium; flow cytometry and antibodies (Abs) have 
been described [28]. Data represent at least two independent experi-
ments using n = 5 mice per group. Significant differences between 
DKO and WT (*) or HET (#) mice are indicated as **p < 0.01; *** or 
###p < 0.001; **** or ####p < 0.0001
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of CDV treatment, Casp8−/−Ripk3−/− mice exhibited higher 
percentages of  KLRG1hi  Ly49H+ NK cells than control 
mice. These data show that the enhancement of  Ly49H+ 
NK cell number in Casp8−/−Ripk3−/− mice requires active 
replication, although CASP8 suppresses NK cell differentia-
tion independent of antigen load.
NK hyperaccumulation in different CASP8‑deficient 
settings
To investigate whether  Ly49H+ NK cell hyperaccumula-
tion occurs with another necroptosis incompetent, CASP8-
deficient strain, NK cells in Casp8−/−Ripk3K51A/K51A mice, 
where the kinase activity has been specifically disrupted 
[33], were compared to Casp8−/−Ripk3−/− as well as WT 
controls. The enhancement of NK cells was observed con-
sistently in either CASP8-deficient setting due to the acti-
vation of  Ly49H+ cells (Fig. 4). Finally, RIPK1 is a death 
domain-containing pro-necroptotic kinase involved in reg-
ulating apoptosis and pro-survival signaling transduction 
as a component of the ripoptosome [25]. To understand 
whether RIPK1 contributed to  Ly49H+ NK cell responses, 
Ripk1−/−Casp8−/−Ripk3−/− mice were infected, and spleno-
cytes were analyzed at 7 dpi. Interestingly, total and  Ly49H+ 
NK cell responses were severely impaired in mice lacking 
RIPK1 at 7 dpi (Fig. 4), even though uninfected mice exhibit 
normal NK cell development [32] and homeostasis [27]. 
This does not appear to be an NK cell-intrinsic dysregulation 
because similar impairment occurs with CD8 T cells (data 
not shown), indicating that RIPK1 contributes to lymphocyte 
response properties in the absence of CASP8 function. Thus, 
CASP8 restricts NK cell accumulation during MCMV infec-
tion; however, RIPK1 supports hyperaccumulation when 
CASP8 and RIPK3 are absent.
Hyperaccumulation of NK cells requires m157–
Ly49H interactions
In C57BL/6 mice, only NK cells express the Ly49H recep-
tor and only  Ly49H+ NK cells respond directly to the viral 
m157-encoded glycoprotein [4, 5].  Ly49H− NK cells are 
stimulated indirectly, although  Ly49H+ NK cells are the 
drivers [3, 34] such that proliferation and cytotoxicity do not 
develop to a demonstrable level during infection with ∆m157 
MCMV [10]. Infection with ∆m157 virus failed to drive 
hyperaccumulation (Fig. 5a) in Casp8−/−Ripk3−/− mice, 
which showed kinetics distinct from WT MCMV, but com-
parable to either Casp8+/−Ripk3−/− or WT mice. Thus, the 
increased accumulation is totally dependent on m157, con-
sistent with data showing  Ly49H+ NK cell hyperaccumula-
tion in MCMV-infected Casp8−/−Ripk3−/− mice (See Fig. 1).
NK cell hyperaccumulation dictates survival 
of antiviral CD8 T cells
∆m157 MCMV has yielded invaluable insights into positive 
and negative impacts of NK cell function on CD8 T cell 
responses [35–38]. In addition to the striking impact on NK 
Fig. 2  Cell-autonomous impact of CASP8 on NK cell expansion and 
contraction during the acute phase of MCMV infection. Equal num-
bers  (106) of the purified TCRβ−NK1.1+ cells from naïve CD45.1+ 
WT mice and CD45.2+ DKO mice were mixed (1:1) and co-trans-
ferred into Ly49H-deficient recipients, followed with MCMV infec-
tion the next day. Graph showing the percentages ± S.E.M. of  Ly49H+ 
cells in blood on days 0, 7, 14, and 28 post infection (a). Representa-
tive plots showing the ratios of WT and DKO  Ly49H+ NK cells in 
blood of the recipients on the indicated days post infection (b). Data 
represent one experiment with n = 3 mice per group
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cell hyperaccumulation, both total (Fig. 5b) and M45-specific 
(Fig. 5c, d) CD8 T cell responses returned to control levels 
during ∆m157 MCMV infection of Casp8−/−Ripk3−/− mice. 
 KLRG1hiCD127lo and  KLRG1hiCD127hi effector subsets 
failed to hyperaccumulate (Fig. 5e). ∆m157 virus infection 
resulted in higher frequencies of fixable viability staining 
 (FVS+) dead cells in spleens of Casp8−/−Ripk3−/− mice 
at 7 dpi compared to m157-expressing K181-BAC virus 
(Fig. 5f), suggesting that the  Ly49H+ NK cell response 
supported Casp8−/−Ripk3−/− splenocyte survival. 
Casp8−/−Ripk3−/− mice exhibited higher frequencies of 
annexin  V+ Casp8−/−Ripk3−/− CD8 T cell subsets (Fig. 5g), 
Fig. 3  Patterns of NK cell 
responses during antigen 
level compromise. Mice were 
administered 5 mg/kg/day CDV 
i.p. in PBS, starting from 3 day 
prior to infection with MCMV 
as described in Fig. 2 and previ-
ously [28]. All groups were 
euthanized and splenocytes 
were analyzed at 7 dpi. Bar 
graphs comparing the numbers 
of total (a) and  Ly49H+ (b) 
NK cells. Data are presented as 
mean ± S.E.M. Representative 
flow plots showing the percent-
ages of  Ly49H+ cells within the 
total NK population (c). Repre-
sentative histograms showing 
the percentage of  Ly49H+ NK 
cells expressing KLRG1 (d). 
Data represent two independent 
experiments with n = 4 mice per 
group
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suggesting that greater numbers of T cells underwent apop-
tosis in Casp8−/−Ripk3−/− mice when the  Ly49H+ NK cell 
response was compromised. Overall, these experiments 
implicate the m157-driven  Ly49H+ NK response in sup-
porting Casp8−/−Ripk3−/− T cell survival as they hyperac-
cumulate following MCMV infection.
To determine whether NK cell-autonomous CASP8 
and RIPK3 contributed to Casp8−/−Ripk3−/− CD8 T 
cell accumulation, CFSE-labeled total CD45.2+ WT or 
Casp8−/−Ripk3−/− splenocytes that contained  106 CD8 T 
cells were transferred into congenic CD45.1+ recipients, 
followed by infection with K181-BAC or ∆m157 virus 
24 h later (Fig. 6a). The numbers of endogenous CD45.1+ 
 Ly49H+ NK cells were comparable in all K181-BAC-
infected recipients but were compromised during infection 
with ∆m157 virus (Fig. 6b). The numbers of responding 
 Ly49H+ NK cells appeared to be generated independ-
ent of the donor cell genotype. Strikingly, hyperaccumu-
lation of total and M45-specific Casp8−/−Ripk3−/− CD8 
T cells was compromised in ∆m157 virus-infected mice 
(Fig. 6c), indicating that WT  Ly49H+ NK cells sufficed to 
enhance Casp8−/−Ripk3−/− CD8 T cell accumulation. Cell 
proliferation assessment by CFSE dilution revealed that 
the m157-driven  Ly49H+ NK cell response did not have 
an impact on Casp8−/−Ripk3−/− CD8 T cell proliferation 
(Fig. 6d), reinforcing the CD8 T cell-intrinsic underpin-
nings of hyperaccumulation [28]. Altogether,  Ly49H+ NK 
cells have an impact independent of CASP8 and RIPK3 on 
Casp8−/−Ripk3−/− CD8 T cell proliferative potential fol-
lowing MCMV infection, by supporting the survival of 
Casp8−/−Ripk3−/− CD8 T cells.
Cytokines, together with m157-driven Ly49H receptor 
signaling, contribute to memory NK cell formation after 
contraction [10]. Memory NK cells express high levels of 
markers related to differentiation and maturation [6]. We 
sought to investigate whether the heightened acute response 
of CASP8-deficient NK cells altered memory formation. NK 
cell numbers and memory cell differentiation markers were 
assessed in WT, Casp8−/−Ripk3−/− and Casp8−/−Ripk3K51A/
K51A mice at 8 wpi. Both CASP8-deficient mutants exhibited 
Fig. 4  Assessment of NK 
cell responses in another 
CASP8-deficienct strain and 
the contribution of RIPK1 
to the response. WT, DKO, 
Casp8–/−Ripk3K51A/K51A 
(C8−/−R3K51A; [33]) and 
Ripk1−/−Casp8−/−Ripk3−/− 
(TKO, [32]) mice were infected 
with MCMV as described in 
Fig. 2. Bar graphs comparing 
the mean numbers ± S.E.M. of 
the splenic total (a),  Ly49H+ 
(b), and  Ly49H− (c) NK cells 
at 7 dpi. Representative flow 
plots showing the percentages 
of  CD45+CD3−B220− cells 
expressing NK1.1 (d) or Ly49H 
(e). Combined data of n = 7 
mice from two independent 
experiments are shown
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lower numbers and percentages of  Ly49H+ NK cells than 
WT controls (Fig. 7), despite hyperaccumulation during the 
acute phase of infection. Enhanced percentages of  KLRG1hi 
 Ly49H+ NK cells were observed in both CASP8-deficient 
settings when compared with controls. The proportion of 
 Ly6C+ NK cells was comparable regardless of genotype, 
suggesting that robust memory NK cell development is 
independent of CASP8 or RIPK3 function. Consistent with 
this observation, over 90% of the cells had a mature NK 
cell phenotype of  CD27loCD11bhi regardless of genotype. 
Thus, CASP8 is dispensable for memory NK cell formation, 
where Bim control of intrinsic apoptosis likely plays the 
central role [20]. The amplified  Ly49H+ NK cell response 
and pattern of enhanced terminal differentiation do not lead 
to better viral control [27], again indicating that the qual-
ity of Casp8−/−Ripk3−/− NK cells may be compromised in 
some ways.
Discussion
Recent studies have highlighted the adaptive immune fea-
tures of NK cells in mice, humans, and nonhuman primates 
[2, 39]. Like the virus-specific CD8 T cell proliferation, sig-
nals through Ly49H receptor, cytokines and co-stimulatory 
molecules together drive efficient NK cell proliferation, dif-
ferentiation and memory development. The extent to which 
cell death machinery contributes to NK cell responses has 
not been fully explored [21]. In the current study, we show 
that CASP8, a critical mediator of extrinsic death pathway 
[23], restricts NK cell expansion during the acute phase of 
MCMV infection but is dispensable for memory NK cell 
formation. These observations seem to parallel the cell-
autonomous role of CASP8 in restraining CD8 T cell prolif-
eration; however, additional studies will be needed to clarify 
this area, particularly given that regulation is independent 
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Fig. 5  Impact of m157-driven NK cells on antiviral CD8 T cell 
responses in DKO mice. WT, HET and DKO mice were inocu-
lated i.p. with 1 × 106 PFU/mouse of K181-BAC or ∆m157 virus 
and mean numbers ± S.E.M. of  Ly49H+ NK cells were determined 
in spleens on days 1.5, 5, 7, and 14 pi (a). Expansion, contraction, 
and phenotype of splenic CD8 T cell response to infection, showing 
mean numbers ± S.E.M. of total CD8 T cells (b) as well as numbers 
(c) and percentages (d) of M45-specific cells on days  5, 7, and 14 
post infection. Bar graphs comparing numbers ± S.E.M. of different 
effector subsets (e, left panel) and representative zebra plots showing 
KLRG1 and CD127 expression (e, right panel) following gating on 
M45-specific CD8 T cells at 7 dpi. Cell death analysis on day 7 post 
infection with K181-BAC or ∆m157 virus, comparing mean frequen-
cies of  FVS+ dead cells in spleens of WT and DKO mice (f), mean 
percentages of annexin  V+ cells within CD8 T cell subset (g) when 
 FVS+ dead cells were excluded from this analysis. Data are presented 
as mean ± S.E.M. and represent two independent experiments with  
n ≥ 4 mice per group
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Fig. 6  Impact of WT m157-driven NK cells on antiviral DKO CD8 
T cell responses. CFSE-labeled total splenocytes containing 1 × 106 
NK cells from naive WT (CD45.2+) or DKO mice (CD45.2+) mice 
were transferred into CD45.1+ WT mice, followed with infection of 
1 × 106 PFU/mouse K181-BAC or ∆m157 the next day followed by 
flow cytometric evaluation of splenocytes at 6  dpi (a). Numbers of 
endogenous CD45.1+  Ly49H+ NK cells in the recipients (b). Bar 
graphs comparing numbers of donor CD45.2+ total CD8 T cells, and 
numbers as well as percentages of CD45.2+ M45-specific cells (c). 
Bar graphs showing the percentages of  CFSElo divided cells within 
the transferred donor CD45.2+ CD8 T cells in the recipients (d)
Fig. 7  Phenotype of NK cells 
in long-term-infected CASP8-
deficient mice. WT, DKO, 
C8−/−R3K51A mice were infected 
and splenocytes were analyzed 
at 60 dpi. Bar graphs comparing 
the numbers (a) and percentages 
(b) of  Ly49H+ NK cells. Graphs 
comparing the percentages of 
 KLRG1hi (c) and  Ly6Chi (d) 
cells within the  Ly49H+ NK 
population. Representative 
flow plots depicting CD27 
versus CD11b expression on 
the NK cell subset (e). Data are 
presented as mean ± S.E.M. and 
represent one experiment with 
mice n = 5 in each group
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of pro-necroptotic RIPK3 but dependent on RIPK1. In addi-
tion to driving hyperaccumulation of  Ly49H+ NK cells in 
Casp8−/−Ripk3−/− mice, the resulting environment supports 
CASP8-deficient T cell survival during expansion, but does 
not appear to directly drive proliferation. Rather, NK and 
CD8 T cell-autonomous CASP8 play different, but interde-
pendent roles once the consequences of RIPK3 necroptosis 
are removed from the host.
Elimination CASP8 together with RIPK3 enhances the 
magnitude of  Ly49H+ NK cell responses, a result remi-
niscent of observations in Bim-deficient mice [20]. Where 
Bim-deficiency impairs memory NK cell development, 
Casp8−/−Ripk3−/− mice do not show defects in NK memory. 
The impact of Bim in T cell memory is likely to be due to 
the importance of intrinsic apoptosis, which is intact in the 
mice we have studied here. Bim alters terminal differentiated 
effector subsets as well as memory precursors accumulat-
ing during the acute phase of virus infection [40], whereas 
combined deficiency in CASP8 and RIPK3 only affects 
the terminal differentiated effector subsets without evident 
impact on the memory precursors [28]. In addition, differ-
ences may be attributable to a death-independent role of 
CASP8 in regulating cell differentiation. CASP8 is likely to 
crosstalk with Akt–mTOR pathway [41], which is important 
for NK cell activation [42, 43]. Thus, disruption of CASP8 
may interfere with NK or other adaptive immune cell dif-
ferentiation through the Akt–mTOR signaling axis, areas 
that are ripe for further investigation.
Studies of CASP8 in NK cells were initially performed 
in patients with a CASP8 catalytic mutation [29, 30] which 
exhibited a defect in NF-κB activation following CD16 or 
2B4 ligation. Whether this result may be compared to results 
of T cell-specific disruption of CASP8 in mice remains to be 
resolved. Importantly, studies in T cell-specific CASP8-defi-
cient mice certainly suffered from unleashed RIPK3-medi-
ated necroptosis that was not recognized at the time but was 
resolved in 2011 [44–46]. The dual elimination of CASP8 
together with RIPK3 removes risk of death and results in 
enhanced  Ly49H+ NK cells response upon MCMV infec-
tion. Thus, as in T cells [28], CASP8 restricts NK cell prolif-
eration once the risk of unleashed necroptosis is eliminated. 
Similar to TCR signal transduction, Ly49H receptor activa-
tion triggers the formation of the CARMA–MALT1–BCL10 
complex that subsequently drives NF-κB activation [47]. 
Studies of T cell signal transduction have shown that this 
complex recruits FADD and CASP8 through the DD inter-
actions between FADD and MALT1 [30, 47, 48]. Given the 
similarity between TCR- and Ly49H-dependent pathways, 
a complex may form directly in association with Ly49H, 
although this may also be influenced by Fas DR activation 
of CASP8 and contribute [49] to Ly49H signal transduction.
By comparing WT and Δm157 virus, we show that a 
robust  Ly49H+ NK cell response supports survival of 
proliferating Casp8−/−Ripk3−/− CD8 T cells, mainly 
affecting the  KLRG1hi subsets that contribute to a higher 
peak CD8 T cell response. Indeed, the normal peak of 
Casp8−/−Ripk3−/−CD8 T cell response following Δm157 
virus infection is reminiscent of patterns observed with 
LCMV-infected mice once T cell-specific CASP8 defi-
ciency was placed on a RIPK3-deficient background 
(Cd4CreCasp8flox/floxRipk3−/−) [46]. In our work,  Ly49H+ 
NK cells promote Casp8−/−Ripk3−/− CD8 T cell survival 
by either reducing viral antigen levels in a critical site or by 
otherwise altering the environment. Curiously, the increased 
accumulation of Casp8−/−Ripk3−/− CD8 T cells following 
TCR stimulation in culture does not require help from other 
immune cells [28], including NK cells. NK cells may sup-
port Casp8−/−Ripk3−/− CD8 T cell survival by metering anti-
gen–TCR interactions in vivo, such as by maintaining DC 
numbers and increasing the amount of viral antigen avail-
able for cross-presentation by DCs. Previous studies show 
that NK cell function influences DC levels during MCMV 
infection [35–38]. Casp8−/−Ripk3−/− CD8 T cell hyperac-
cumulation may result from the more sustained antigen 
stimulation that occurs in vivo but through some de facto 
quality of in vitro stimulation assays [35–38]. Sustained DC 
levels would be expected to drive terminal differentiated 
 KLRG1hiCD127lo cell accumulation, which depend more on 
sustained TCR stimulation than their  KLRG1lo counterparts 
[18]. Therefore, hyperaccumulation is an inherent feature of 
Casp8−/−Ripk3−/− T cells following TCR stimulation and is 
maintained via a NK cell-dependent survival mechanism 
during herpesvirus infection.
The function of Casp8 in NK cell regulation beyond 
suppressing necroptosis remains unknown, although this 
intensely studied protease has many uncharacterized sub-
strates, oligomerization states and interaction partners [25]. 
We show that Casp8 restricts  Ly49H+ NK cell expansion 
with no obvious impact on  Ly49H− NK cell levels. Strik-
ingly, NK cell responses are ablated once RIPK1 is elimi-
nated along with Casp8 and RIPK3. Thus, Casp8 and 
RIPK1, likely via a FADD bridge in a ripoptosome-like 
complex, collaborate to influence NK cell responses fol-
lowing infection.
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